CLEMSON, S.C. – Clemson University and Greenville-based health tech company Rymedi announced an expanded partnership on Tuesday. Rymedi is designated as an official sponsor of Clemson Athletics.
Rymedi was integral throughout the past several years as part of the University’s return-to-class and return-to-play strategies stemming from the ongoing pandemic. Rymedi built the technology platform that organized and communicated testing results for thousands on campus and in the local community. This effort enabled more than one million PCR COVID-19 tests on Clemson’s campus and thousands more within athletics to better provide a safe opportunity to compete.
“We are excited about the opportunity to partner with Rymedi, which ties together a locally-owned business and an innovative set of services that has already had a big impact on Clemson Athletics,” said Clemson Director of Athletics Graham Neff. “The collaboration with our campus partners is unique, and we appreciate Rymedi for its demonstrated commitment to our community.”
This marketing-based partnership with Clemson Athletic Properties will enable Rymedi to more closely align with the University through athletics-focused advertising and social media engagement.
As a Strategic Corporate Partner of the University since 2020, Rymedi continues its contributions to academic and research efforts. The institutional partnership supports collaboration and innovation for students and faculty, allowing students to gain valuable knowledge in the life sciences industry through internships, while also providing research support to students and faculty.
“From the initial partnership focused on our (Rymedi) technology platform enabling students, faculty and staff to get back to campus safely, to supporting research and now this opportunity with athletics, it’s exciting to expand our partnership and work with all facets of the University,” said David Stefanich, co-founder and CEO of Rymedi.
Rymedi’s technology platform and team have also played a key role in enhancing the University’s capabilities for health programs and research. Running on Rymedi, the REDDI Lab led by Delphine Dean, Ph.D. is testing for campus and community health, while contributing to national research and disease surveillance programs. Clemson researchers also leverage Rymedi’s platform to participate in clinical trials.
Stefanich currently serves on the University’s Industry Advisory Board, providing input and insight related to his work in the life sciences industry in South Carolina. Stefanich and other Rymedi team members have also shared their expertise with students and faculty through panel discussions and support of research proposals.
“The partnership with Rymedi is a great example of how we collaborate with industry and extend beyond traditional corporate engagement,” said Jack Ellenberg, associate vice president of External Affairs. “Partners have the ability to find unique ways to engage with faculty, students, researchers and fans of the University.”
